Trademark applications and grants for Csl L T D. Csl L T D has 71 trademark applications. The latest application filed is for "AFLURIA INFLUENZA VACCINE"
Patent Application | Date |
---|---|
RECONSTITUTED HIGH DENSITY LIPOPROTEIN FORMULATION AND PRODUCTION METHOD THEREOF 20220133852 - 17/368464 Wright; Samuel ;   et al. | 2022-05-05 |
COAGULATION FACTOR BINDING PROTEINS AND USES THEREOF 20220089778 - 17/450423 SCHMIDT; Peter ;   et al. | 2022-03-24 |
METHOD OF TREATING ATHEROSCLEROSIS 20220017638 - 17/498112 PANOUSIS; Con ;   et al. | 2022-01-20 |
CD131 BINDING PROTEINS AND USES THEREOF 20210324091 - 16/953499 OWCZAREK; Catherine ;   et al. | 2021-10-21 |
METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RECONSTITUTION 20210308229 - 17/109366 HORN; Carsten ;   et al. | 2021-10-07 |
NCAGE Code | Z0UJ1 | CSL LIMITED |
CAGE Code | Z0UJ1 | CSL LIMITED |
SEC | 0001274152 | CSL LTD |
SEC | 0000924498 | CSL LTD /FI |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.